Green Thumb Industries (GTBIF) Share-based Compensation (2019 - 2026)
Green Thumb Industries (GTBIF) posted Share-based Compensation of $50.5 million for Q1 2026, up 333.72% on a QoQ basis from $11.7 million in Q3 2025, and up 390.31% year-over-year from $10.3 million in Q1 2025.
Green Thumb Industries (GTBIF) Share-based Compensation (2019 - 2026) Analysis & Trends
Green Thumb Industries' Share-based Compensation history runs 8 years deep, the most recent figure standing at $50.5 million for Q1 2026.
- Quarterly Share-based Compensation rose 390.31% year-over-year to $50.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $50.5 million (up 36.13% YoY) and the FY2025 annual result came in at $61.4 million, down 20.75% from the prior year.
- Share-based Compensation was $50.5 million for Q1 2026 at Green Thumb Industries, up from $11.7 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $50.5 million in Q1 2026 and bottomed at $6.2 million in Q1 2023.
- A 5-year average of $11.3 million and a median of $8.1 million in 2022 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2023 — Share-based Compensation plunged 52.41% — and 2026, when it soared 390.31%.
- Green Thumb Industries' Share-based Compensation stood at $7.8 million in 2022, then declined by 5.45% to $7.4 million in 2023, then surged by 30.64% to $9.6 million in 2024, then increased by 21.31% to $11.7 million in 2025, then soared by 333.72% to $50.5 million in 2026.
- Business Quant data shows GTBIF's Share-based Compensation at $50.5 million in Q1 2026, $11.7 million in Q3 2025, and $12.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 43.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 25.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 125.69 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 58.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 56.50 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 55.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.00 Mn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | 50.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.55 Mn |
| Mar 31, 2026 | 50.55 Mn |
| Sep 30, 2025 | 11.65 Mn |
| Sep 30, 2025 | 11.65 Mn |
| Jun 30, 2025 | 11.97 Mn |
| Jun 30, 2025 | 11.97 Mn |
| Mar 31, 2025 | 10.31 Mn |
| Mar 31, 2025 | 10.31 Mn |
| Dec 31, 2024 | 9.61 Mn |
| Dec 31, 2024 | 9.61 Mn |
| Sep 30, 2024 | 8.35 Mn |
| Sep 30, 2024 | 8.35 Mn |
| Jun 30, 2024 | 8.87 Mn |
| Jun 30, 2024 | 8.87 Mn |
| Mar 31, 2024 | 6.49 Mn |
| Mar 31, 2024 | 6.49 Mn |
| Dec 31, 2023 | 7.35 Mn |
| Dec 31, 2023 | 7.35 Mn |
| Sep 30, 2023 | 7.22 Mn |
| Sep 30, 2023 | 7.22 Mn |